PUBLIC CONTRACT · 2025

1784/2025 - Convite à apresentação de proposta por ajuste direto para aquisição de R1100 - RISPERIDONA [75 MG/0.383 ML; PÓ SUSP INJ LP; SERINGA], e R1101 - RISPERIDONA [100 MG/0.490 ML; PÓ SUSP INJ LP; SERINGA] PARA SUPRIR NECESSIDADES DAS ENTIDADES DO SNS

Contract value
€5,277.40
Signed on
21 October 2025
Procedure
Direct award, general (Ajuste Direto Regime Geral)

This page lays out the fields published on Portal BASE and says when a field is unavailable. It is not an assessment of the contract's merit, legality or impact.

Record 11867124

PUBLISHED DESCRIPTION

1784/2025 - Convite à apresentação de proposta por ajuste direto para aquisição de R1100 - RISPERIDONA [75 MG/0.383 ML; PÓ SUSP INJ LP; SERINGA], e R1101 - RISPERIDONA [100 MG/0.490 ML; PÓ SUSP INJ LP

Parties involved

Place of performance
Portugal, Braganca
NUTS region
PT11E - Terras de Trás-os-Montes

WHO BID

Awardee and competitors

Companies that IMPIC lists as the awardee and as competitors in this procedure.

Awardee
LAB. FARMACEUTICOS ROVI, SA. · Tax ID 980166705

Values and timeline

Contract price
€5,277.40
Procedure base price
€215,078.17
Total effective price
Not reported on Portal BASE
Publication date
30 October 2025
Award date
17 October 2025
Signing date
21 October 2025
Performance period
92 days

The contract price is the value agreed in the contract, not the amount paid.

Procedure and framework

Contract type
Aquisição de bens móveis
Award criterion
Monofator
CPV code
33600000-6 - Produtos farmacêuticos
Legal basis
Artigo 24.º, n.º 1, alínea e), subalínea ii) do Código dos Contratos Públicos
Regime
Código dos Contratos Públicos (DL111-B/2017) e Lei n.º 30/2021, de 21.05
Framework agreement
Not stated
Centralised procedure
Yes
Environmental criterion
No
Notice
Not stated
Procedure identifier
7932491

Compare with other contracts

Search the same body, supplier, place or type of service to understand the context of the published index.

← Back to contracts